Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity
NCT ID: NCT02822027
Last Updated: 2022-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2016-06-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Erythropoietin on Preterm Brain Injury
NCT02036073
Effect of Erythropoietin in Premature Infants on White Matter Lesions and Neurodevelopmental Outcome
NCT03110341
Effect of Erythropoietin on Neurodevelopmental Outcomes in Very Preterm Infants With Intraventricular Hemorrhage
NCT03914690
Transfusion of Prematures Trial
NCT01702805
Erythropoietin in Premature Infants to Prevent Encephalopathy
NCT02550054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
human gamma globulin
human gamma globulin for infants with encephalopathy of prematurities
human gamma globulin
human gamma globulin for preterm infants with encephalopathy of prematurities
non-human gamma globulin
Non-human gamma globulin for preterm infants with encephalopathy of prematurities
non-human gamma globulin
non-human gamma globulin for infants with encephalopathy of prematurities
human gamma globulin
human gamma globulin for preterm infants with encephalopathy of prematurities
non-human gamma globulin
Non-human gamma globulin for preterm infants with encephalopathy of prematurities
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
human gamma globulin
human gamma globulin for preterm infants with encephalopathy of prematurities
non-human gamma globulin
Non-human gamma globulin for preterm infants with encephalopathy of prematurities
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fang Wu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pediatrics,Daping Hospital
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IVIG for encephalopathy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.